Definitive Healthcare Corp. (NASDAQ:DH) Receives $5.81 Average Price Target from Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have received a consensus recommendation of “Hold” from the eleven analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $5.81.

A number of analysts recently weighed in on the stock. Stifel Nicolaus decreased their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a report on Wednesday, July 31st. Morgan Stanley cut their price target on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 6th. JPMorgan Chase & Co. cut shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and cut their price target for the stock from $7.00 to $5.00 in a research note on Wednesday, July 31st. Robert W. Baird cut their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th.

Definitive Healthcare Stock Performance

Definitive Healthcare stock opened at $4.52 on Friday. The firm’s 50 day simple moving average is $4.36 and its 200 day simple moving average is $4.95. The company has a current ratio of 2.49, a quick ratio of 2.40 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $522.15 million, a PE ratio of -1.46, a price-to-earnings-growth ratio of 6.67 and a beta of 1.33. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Institutional Trading of Definitive Healthcare

Several large investors have recently added to or reduced their stakes in DH. Millennium Management LLC bought a new position in shares of Definitive Healthcare in the second quarter worth approximately $9,283,000. Massachusetts Financial Services Co. MA boosted its position in shares of Definitive Healthcare by 36.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after purchasing an additional 1,626,813 shares during the period. 272 Capital LP bought a new position in shares of Definitive Healthcare in the second quarter worth approximately $3,480,000. Marshall Wace LLP bought a new position in shares of Definitive Healthcare in the second quarter worth approximately $1,535,000. Finally, Algert Global LLC bought a new position in shares of Definitive Healthcare in the second quarter worth approximately $1,265,000. 98.67% of the stock is currently owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.